N-methyl-D-aspartate receptors (NMDAR) overactivation is linked to neurodegeneration. The current prevailing theory suggests that synaptic and extrasynaptic NMDAR (syn-and ex-NMDAR) impose counteracting effects on cell fate, and neuronal cell death is mainly mediated by the activation of ex-NMDAR. However, several lines of evidence implicate the limitation of this theory. Here, we demonstrate that activation of NMDAR bi-directionally regulated cell fate through stimulating pro-survival or pro-death signaling. While low-dose NMDA preferentially activated syn-NMDAR and stimulated the extracellular signal-regulated kinase ½-cAMP responsive element-binding protein-brain-derived neurotrophic factor pro-survival signaling, higher doses progressively activated increasing amount of ex-NMDAR along with syn-NMDAR and triggered cell death program. Interestingly, the activation of syn-or ex-NMDAR alone did not cause measurable cell death. Consistently, activation of syn-or ex-NMDAR alone stimulated pro-survival but not pro-death signaling. Next, we found that memantine, which was previously identified as an ex-NMDAR blocker, inhibited intracellular signaling mediated by syn-or ex-NMDAR. Simultaneous blockade of syn-and ex-NMDAR by memantine dose-dependently attenuated NMDAR-mediated death. Moreover, long-but not short-term treatment with high-dose NMDA or oxygen-glucose deprivation triggered cell death and suppressed pro-survival signaling. These data implicate that activation of syn-or ex-NMDAR alone is not neurotoxic. The degree of excitotoxicity depends on the magnitude and duration of syn-and ex-NMDAR coactivation. Finally, genome-wide examination demonstrated that the activation of syn-and ex-NMDAR lead to significant overlapping rather than counteracting transcriptional responses.
We further provide new evidence to show that the degree of NMDAR-dependent excitotoxicity is related to the magnitude and duration of syn-and ex-NMDAR coactivation. Moreover, data from microarray analysis showed that activation of synand ex-NMDAR had overlapping but not opposing effects on genomic responses.
Results
NMDAR bi-directionally regulates pro-survival signaling and intracellular Ca 2 þ homeostasis. Previous studies show that the activation of NMDAR bi-directionally regulates intracellular responses related to neuronal survival. 18 Here, we stimulated neurons with various concentrations of NMDA for 30 min, and examined intracellular responses related to neuronal fate. Consistent with previous studies, 18, 19 we found that lower concentration of NMDA (at 15 and 20 mM) upregulated extracellular signal-regulated kinase ½ (ERK1/2) phosphorylation, and higher NMDA deactivated ERK1/2 ( Figure 1a ). NMDA also bi-directionally regulated the transcription of a pro-survival gene brain-derived neurotrophic factor (Bdnf) (Figure 1b ). Moreover, low-dose NMDA activated the pro-survival molecules CREB and AKT; high doses shut them off (Figures 1c and d) . In correlation, NMDA triggered the activation of a pro-death molecule caspase-3 ( Figures 1c and d) , and neuronal death (Figures 1e and f) in a dose-dependent manner. Increasing NMDA concentrations also progressively triggered more lactate dehydrogenase release from damaged neurons (Supplementary Figure 1) .
The Ca 2 þ overload and loss of Ca 2 þ homeostasis triggered by NMDAR overactivation is highly related to neuronal death. 20 By measuring intracellular Ca 2 þ (Ca (Figures 1e and f ). These data demonstrate that increasing amount of NMDA activated more receptors, which contribute to a program switch from survival to cell death.
Activation of syn-NMDAR alone triggers pro-survival signaling but not death. Why does bath incubation with NMDA at different concentrations lead to different neuronal responses? One possibility is that there is a threshold of NMDAR activation, surpassing which will trigger the prodeath program. 21 The other possibility is that low-dose NMDA mainly activates syn-NMDAR; high-dose NMDA activates more receptors including ex-NMDAR, which was suggested as the major cause for cell death by previous studies. 7 Here, we demonstrate that bicuculline and 15 mM NMDA had similar effects. It is known that bicuculline, a GABA A receptor antagonist, activates syn-NMDAR by blocking synaptic inhibition and thereby leading to glutamate release from presynaptic terminals. 22 First, bicuculline treatment activated CREB and AKT but not caspase-3 ( Figure 2a ). Bicuculline also upregulated ERK1/2 phosphorylation ( Figure 2b ) and Bdnf transcription (Figure 2c ). Second, a 30-min treatment with bicuculline did not cause any detectable cell death (Figure 2d) . A long-term 24-h treatment with bicuculline or 15 mM NMDA also failed to induce death (Figure 2e ).
Activation of ex-NMDAR alone does not cause neuronal death but instead activates pro-survival signaling. To determine the function of ex-NMDAR, we used a wellaccepted method to block syn-NMDAR by treating neurons with bicuculline and MK801. Because bicuculline only activates syn-NMDAR and MK801 irreversibly blocks the opened channels, cotreatment with bicuculline plus MK801 would block syn-NMDAR. Thus, any subsequent NMDARmediated responses would be attributed to ex-NMDAR. Bicuculline and MK801 caused a transient syn-NMDARmediated Ca 2 þ influx (Supplementary Figure 2A) . After removing bicuculline/MK801, subsequent application of bicuculline no longer induced any measurable Ca 2 þ influx (Supplementary Figure 2B) . Neurons cotreated with bicuculline/MK801 did not show CREB activation (Supplementary Figure 2C) . Following bicuculline/MK801 pretreatment, subsequent bicuculline did not upregulate CREB phosphorylation (p-CREB) (Supplementary Figure 2D ). These results demonstrate that cotreatment with bicuculline/MK801 sufficiently blocked syn-NMDAR.
Following bicuculline/MK801 and a subsequent wash, we examined the changes of Ca 2 þ i by applying increasing concentrations of NMDA. We found that NMDA from 15 to 50 mM progressively induced increasing degrees of Ca 2 þ i elevation (Figures 3a-e ). This indicates that higher doses of NMDA activated more ex-NMDAR. We noticed that, after blocking syn-NMDAR, NMDA at 20 to 50 mM no longer caused Ca 2 þ dysregulation. After NMDA withdrawal, the elevated Ca 2 þ i decreased toward the baseline level (Figures 3b-e) . These data suggest that activation of ex-NMDAR alone does not disrupt Ca 2 þ homeostasis. Consistently, no significant cell death was observed with neurons stimulated with higher NMDA following bicuculline/ MK801 pretreatment (Figure 3f ). Further, with syn-NMDAR blocked, NMDA or glutamate at as high as 1 mM failed to cause measurable death (Supplementary Figure 3A) . Moreover, after blocking syn-NMDARs, 100 mM NMDA or 100 mM glutamate incubation for 24 h failed to induce death (Supplementary Figure 3B) . Because previous observations suggest that bicuculline pretreatment has a protective effect on NMDA-induced cell death, 23 we wondered whether the presence of bicuculline during the 2-min pretreatment with bicuculline/MK801 has a similar effect. However, we did not observe any protective effect from the 2-min bicuculline pretreatment (Supplementary Figure 4) . Together, we show that activation of syn-or ex-NMDAR alone was not sufficient to cause measurable cell death and Ca 2 þ dysregulation. Activation of syn-NMDAR along with increasing involvement of extrasynaptic receptor, as in the cases when neurons were treated with increasing concentrations of NMDA (Figures 1e  and f) , was neurotoxic.
To further determine the function of ex-NMDARs under pathological conditions, we used oxygen-glucose deprivation (OGD) as a cellular ischemic stroke model. 24 A 75-min OGD induced 73.6% cell death (Figure 4a ). After blocking synNMDARs, OGD did not cause significant death (Figure 4a ). Consistently, OGD caused a reduction in p-CREB and p-AKT along with an elevation of caspase-3 activity (Figure 4b ). After blocking syn-NMDAR, OGD upregulated p-CREB and p-AKT without elevating caspase-3 ( Figure 4b ). We are aware of the possible NMDAR-independent mechanisms in OGD. Under our experimental setup, 2 h of OGD caused severe cell death with or without bicuculline/MK801 pretreatment (Supplementary Figure 5) . When the duration of the OGD reduced to 75 min, there is a clear functional involvement of NMDAR. Our data show that this 'NMDAR-involved phase' is not sensitive to OGD when synaptic receptors are blocked.
To seek direct evidence on why extrasynaptic activation failed to induce death, we stimulated neurons with different concentrations of NMDA after blocking the synaptic receptors. In neurons pretreated with bicuculline/MK801, NMDA at 15 mM did not cause significant phosphorylation of CREB, AKT (Figure 5a ), and ERK1/2 (Figure 5b ), as well as Bdnf transcription (Figure 5c ). This is consistent with the result in Figure 3a , which shows that 15 mM NMDA failed to significantly activate ex-NMDAR and trigger Ca 2 þ influx. Activation of ex-NMDAR by higher concentrations of NMDA (at 20, 30, 40 or 50 mM) stimulated these survival-related signaling pathways (Figures 5a-c) , without activating caspase-3 ( Figure 5a ) and lactate dehydrogenase release (Supplementary Figure 6) . These results provide molecular mechanisms supporting that activation of ex-NMDAR alone is not sufficient to cause death. Figure 7) . Together, we suggest that activation of either syn-or ex-NMDAR alone is not sufficient to promote cell death. Switching intracellular program from pro-survival to pro-death may require certain degree of coactivation of NMDAR at both sub-cellular locations.
Memantine blocks intracellular signaling mediated by either syn-or ex-NMDAR. Memantine, a non-competitive low affinity NMDAR antagonist, has been used for the treatment of moderate-to-severe Alzheimer's disease. 25 Some electrophysiological examinations implicated that memantine preferentially affects ex-NMDAR (Xia et al. 26 but also see Wroge et al. 27 ), although how memantine affects intracellular signaling related to survival and death remains unclear. To test its effects on syn-NMDAR-mediated signaling, we treated neurons with bicuculline in the presence of different concentrations of memantine. Memantine at 1 mM marginally suppressed bicuculline-stimulated p-CREB (Figure 6a ). The phosphorylation of CREB was significantly and fully blocked by 10 and 100 mM memantine, respectively. Similarly, memantine also blocked 15 mM NMDA-induced p-CREB elevation in a concentration-dependent manner ( Figure 6b ). Next, we found that memantine at 1 and 10 mM marginally and partially blocked p-CREB triggered by ex-NMDAR, respectively (Figure 6c ). Memantine at 100 mM completely blocked p-CREB stimulated by ex-NMDAR activation (Figure 6c ). These data implicate that memantine non-selectively blocks both synaptic and extrasynaptic receptors.
We next investigated the effects of simultaneous blockage of synaptic and extrasynaptic receptors (i.e., by memantine) on NMDAR-dependent excitotoxicity. Memantine at 1 mM slightly reduced NMDA-induced neuronal death (72.1±5.6% versus 66.2±5.1%, Po0.05). Memantine at 10 mM greatly attenuated cell death (32.4±4.2%), and 100 mM memantine reduced cell death to the control level (5.4 ± 2.9 versus 4.5±3.2% in control) (Figure 6d ). These results along with the data in Figure 1 implicate that the degree of NMDAinduced death depends on the magnitude of coactivation of NMDAR at both sub-cellular locations.
Transient coactivation of syn-and ex-NMDAR does not cause cell death. It has been established that OGD triggers to treat ischemic stoke, and also suggest that short-term coactivation of syn-and ex-NMDAR is not toxic. Next, we examined how short-term incubation with NMDA affected death. We used 15 mM NMDA to preferentially activate syn-NMDA, and 50 mM NMDA to coactivate both syn-and ex-NMDAR. As shown in Figures 7c and e, a 2-to 10-min stimulation with 15 mM NMDA caused significant p-CREB upregulation. However, while a short (2-to 4-min) stimulation with 50 mM NMDA upregulated p-CREB, a longer stimulation (more than 6 min) failed to activate CREB (Figures 7d and e) . As shown in Figure 1c , a 30-min incubation with 50 mM NMDA significantly deactivated CREB. Consistently, incubation with 50 mM NMDA for up to 4 min did not cause significant death, but longer incubation did (Figure 7f) . By extending the duration of NMDA insult to 60 min, 20 mM but not 15 mM NMDA started to deactivate CREB (Supplementary Figure 8) . While stimulation with 20 mM NMDA for 30 min caused mild cytotoxicity (Figure 1f ), a 24-h stimulation resulted in severe cell death (Supplementary Figure 9) . These data indicate that the NMDAR-mediated cell death depends on both the magnitude and duration of synaptic and extrasynaptic receptor coactivation.
Activation of syn-and ex-NMDAR leads to overlapping genomic responses. Although previous studies suggested that syn-and ex-NMDAR causes opposing effects, our data showed that they both stimulated pro-survival signaling and turned on the transcription of a CREB target gene Bdnf. We further determined how genome-wide expression profiles were regulated by NMDAR at different locations. By using false discovery rate of 25% as the threshold, we identified upregulated and downregulated genes from the Affymetrix GeneChip (Affymetrix, Santa Clara, CA, USA) Rat Gene 1.0 ST Arrays. Activation of syn-NMDAR up-regulated the expression of 226 genes, and downregulated 750 genes (Supplementary Table 1 ). Following ex-NMDAR activation, 29 genes were upregulated and four genes were downregulated (Supplementary Table 2 ). Interestingly, activation of syn-and ex-NMDAR triggered overlapping rather than opposing genomic responses (Figure 8a ). Over 60% of the genes upregulated by ex-NMDAR were also upregulated by syn-NMDAR (Figures 8a and b) . Two genes were (Figure 8c) . The microarray data also demonstrated that Bdnf expression was upregulated by both syn-and ex-NMDAR (Figure 8b ). TRANSFACT analysis of the coactivated genes revealed that both syn-and ex-NMDAR might have stimulated the transcription factors such as CREB, ATF, KROX, E2F, and SRF ( Figure 8b ).
Discussion
Since the discovery of NMDAR involvement in neurodegeneration, numerous molecular determinants of cell death have been identified by stimulating neurons with NMDAR agonists. Intriguingly, neurons often do not show the same response to different concentrations of the agonists. Chandler et al.
18
showed that NMDA at 10 or 20 mM upregulated ERK1/2 activity, but 100 mM NMDA caused down-regulation. Consistent with the bi-directional regulation of the pro-survival molecule ERK1/2, we demonstrated that high but not lowdose NMDA triggered cell death. Although most studies presume that bath NMDA or glutamate treatment causes death through ex-NMDAR activation, we provide new evidence demonstrating that the degree of NMDAR-mediated excitotoxicity depends on the magnitude and duration of synand ex-NMDAR coactivation.
One novel and surprising finding of this study is that we found no obvious causal effects of ex-NMDAR activation on death. This is in contrast to the prevailing hypothesis, emphasizing that ex-NMDAR contributes to excitotoxicity by shutting off pro-survival signaling. 7, 8, 28 By carefully controlling NMDAR activation at different locations, we showed that blocking syn-NMDAR ablated cell death after high-dose NMDA or OGD. Supportively, after blocking syn-NMDAR, the activation of the available ex-NMDAR stimulated the ERK1/2-CREB-Bdnf pro-survival signaling. This is consistent with a recent study, which demonstrated that 50 mM glutamate failed to induce death after bicuculline/MK801 pretreatment. 27 A previous study also showed that partial reduction of syn-NMDAR attenuates OGD-induced death. 29 Further, Gao et al. 30 showed that ERK1/2 activity was not suppressed by ex-NMDAR activation. The fact that immature developing neurons or retinal ganglion cells, which mainly express ex-NMDAR, 1216,17 are resistant to NMDA-or glutamate-induced cell death [13] [14] [15] is in line with our conclusion.
An important support for the deleterious role of ex-NMDAR is from the pro-survival effect of memantine, which has been found to preferentially block ex-NMDAR. 26 However, this is based on the assumption that bath application of 100 mM NMDA only activates ex-NMDAR. Recently, Wroge Figure 6 Memantine blocks intracellular CREB signaling mediated by either syn-or ex-NMDAR. DIV 14 neurons were stimulated with bicuculline (a), or 15 mM NMDA (b), or 100 mM NMDA following a 2-min pretreatment with bicuculline/MK801 (c). Memantine at different concentrations was coapplied with the stimulants. Thirty minutes after the stimulation, samples were harvested, and the level of p-CREB was determined by western blot. (d) Memantine blocks NMDAR-mediated cell death in a dose-dependent manner. Different doses of memantine were coapplied with 100 mM NMDA for 30 min. Twenty hours after the removal of NMDA, cell death was determined by DAPI staining. Statistical difference (Po0.05) was revealed by ANOVA. Different letters indicate distinct SNK groups with aobocodoe for different measurements Dissecting NMDAR in neuronal fate X Zhou et al and colleagues 27 showed that memantine significantly attenuates current mediated by both syn-and ex-NMDAR. We demonstrate that memantine at both low (e.g., 1 or 10 mM) and high doses (e.g., 100 mM) blocks CREB activation mediated by either syn-or ex-NMDAR. Its effects on syn-NMDAR is consistent with previous reports, showing that memantine partially inhibits the induction of LTP and learning, which depend on syn-NMDAR function. 31 Because simultaneous blocking syn-and ex-NMDAR by memantine dose-dependently suppressed excitotoxicity, we conclude that the magnitude of coactivation of these receptors determines the degree of cell death. Although we demonstrated that syn-NMDAR activation did not cause death, we cannot exclude the detrimental effects of syn-NMDAR overactivation under some extreme conditions. For example, blocking the removal of synaptically released glutamate by TBOA (a glutamate transporter inhibitor) exaggerates hypoxic excitotoxic death. 27 In cocultures that contain 95% neuron and 5% glia, promoting glutamate uptake reversal causes significant cell death via syn-NMDAR activation. 32 Another important finding of this study is that NMDARmediated cell death also depends on the duration of syn-and ex-NMDAR coactivation. A short-term OGD or a brief exposure to the excitotoxic dose of NMDA was not effective to cause death. Rather, short-term coactivation of syn-and ex-NMDAR triggered pro-survival responses. One possibility is that these brief insults do not lead to full coactivation of synand ex-NMDAR. Figures 3b-d show that the rise in Ca (Figure 3d ). This implicates that ex-NMDARs may be slow-responding receptors, whose full activation may need prolonged ligand exposure. Therefore, when both synaptic and extrasynaptic receptors are available, OGD or bath incubation with high NMDA (e.g., 50 mM) may first rapidly activate synaptic receptors along with a small population of ex-NMDAR, and then gradually activate increasing number of ex-NMDARs. Such feature of ex-NMDAR may help neurons to escape from death during sub-damaging and short-term insults.
Although there were attempts to determine how the wholegenome programming responds to NMDAR activation, this is the first microarray study that isolates the role of syn-and ex-NMDAR. The study by Hong and colleagues 33 examined limited number of genes (i.e., 1152) by using a custom microarray. There is minimal overlap of genomic changes when comparing their study with ours, possibly because they mainly examined late responses at up to 24 h after NMDA stimulation. The other study by Zhang et al. 34 compared early genomic changes triggered by bicuculline and 20 mM glutamate, which only shut off CREB without causing acute necrosis. By using a different neuron type (i.e., hippocampal neurons), Zhang et al. 34 found opposing effects of bicuculline and 20 mM glutamate on transcriptional responses. However, the study also revealed that significant amount of changes triggered by 20 mM glutamate (53/106 upregulated genes and 10/51 downregulated genes) overlapped with those triggered by bicuculline. Here, we clearly demonstrate that activation of syn-and ex-NMDAR did not lead to opposing genomic responses. The overlap in expression changes was significant, consistent with that syn-and ex-NMDAR both activated CREB signaling and certain CREB target genes.
We found that syn-NMDAR triggered changes in significantly more genes than ex-NMDAR. This is consistent with that, comparing with broader brain functions mediated by syn-NMDAR, ex-NMDAR has limited roles. Certain physiological functions of ex-NMDAR are implicated in enhancing synaptic signaling and temporal coordination of synaptic firing. 10, 11 Ex-NMDAR may also serve as reserves for the activity-dependent lateral incorporation to synapses. 35, 36 The different genomic responses triggered by syn-and ex-NMDAR may be attributed to difference in receptor density and regulatory property. For example, synand ex-NMDAR are differentially regulated by calcium and tyrosine phosphorylation. 12 Differential interaction with the scaffolding network and receptor subunit composition along with different splicing variants may lead to distinct linkage to different intracellular cascades. 37, 38 The cellular and molecular determinants require further investigation.
Materials and Methods
Primary neuronal culture. Primary cortical neurons were obtained from postnatal day 0 Sprague Dawley rats as previously described. 39 The Institutional Animal Care and Use Committee at Michigan State University has approved the procedures used in this study. Cultures were maintained in Neurobasal A, 1 Â B27 supplement (Invitrogen, Carlsbad, CA, USA), 100 units/ml penicillin, 0.1 mg/ml streptomycin, and 0.5 mM glutamine. One-third of the medium was replenished every 3 days during the culturing. Neurons at DIV (days in vitro) 14 were used for experiments.
Neuronal stimulation. All stimulations were done after a 30-min pretreatment with 20 mM CNQX (Sigma, St Louis, MO, USA) and 5 mM nifedipine (Sigma), which block the non-NMDA-type glutamate receptors and L-type voltage-gated calcium channels, respectively. NMDAR coagonist glycine (2 mM) was coapplied with stimulants. To achieve global activation of NMDAR, neurons were stimulated with NMDA at different concentrations (as indicated). To stimulate syn-NMDAR, 50 mM bicuculline was applied. To stimulate ex-NMDAR, neurons were first treated with 50 mM bicuculline and 10 mM MK801 for 2 min, washed three times with prewarmed conditioned media, and then incubated in conditioned media with 50 mM NMDA (or at other concentrations as indicated). All drugs were applied directly to the medium, and the neurons were maintained at 37 1C with 5% CO 2 during all treatments.
Western blot and quantification. After stimulation (30 min or as indicated), samples were collected in 60 ml of SDS sample buffer (10 mM TrisHCl buffer, pH 6.8, 10% glycerol, 2% sodium dodecylsulfate, 0.01% bromophenol blue and 5% b-mercaptoethanol), and boiled at 100 1C for 10 min. The extracts (from about 8 Â 10 5 cells) were separated by 10% SDS-PAGE, transferred to nitrocellulose membranes, and blocked with 5% non-fat milk in PBS-T (PBS, 0.1% Triton X-100) for 30 min at room temperature. The membranes were then incubated with primary antibodies against phosphorylated ERK1/2 (p-ERK1/2; 1:1000; Cell Signaling Technology, Beverly, MA, USA), phosphorylated CREB (p-CREB at Ser133; 1:1000; Upstate, Lake Placid, NY, USA), phosphorylated AKT (p-AKT at Ser473; 1:1000; Cell Signaling), and cleaved caspase-3 (1:1000, Cell signaling) in PBS-T overnight at 4 1C. After extensive wash and incubation with horseradish peroxidase-conjugated goat antirabbit antibodies (1:5000; Pierce, Rockford, IL, USA), the signals were detected by the chemiluminescence method (SuperSignal West Pico, Pierce, Rockford, IL, USA). For the purpose of normalization, the membranes were stripped, and re-probed with antibodies against b-actin (1:10,000; Sigma, St Louis, MO, USA). Several exposure times were used to obtain signals in the linear range. The bands were quantified by using Scion Image Beta 4.0.2 software (Scion Corp. Frederick, MD).
Semi-quantitative RT-PCR. To measure the agonist-stimulated transcription of Bdnf exon 4, control and stimulated neurons were lysed, and total RNA was purified by using the TRIzol method (Invitrogen). The cDNA was synthesized from 0.5 mg total RNA by using the reverse transcription kit (SuperScript, Invitrogen), and subjected to PCR. The primers used for exon 4-containing Bdnf mRNA are: 5 0 -CTCCGCCATGCAATTTCCAC-3 0 (forward), and 5 0 -GCCTTCATGCAACC GAAGTA-3 0 (reverse). These primers produced a 274-bp PCR product. PCR amplification of GAPDH using 5 0 -TCCATGACAACTTTGGCATTGTGG-3 0 and 5 0 -GTTGCTGTTGAAGTCGCAGGAGAC-3 0 was used as the internal control. The cycle number for Bdnf exon 4 and GAPDH was 26 and 20, respectively. The semiquantitative RT-PCR products were analyzed by agarose gel electrophoresis, and quantified by Scion Image software.
